MARKET

HROW

HROW

Harrow Health Inc
NASDAQ
35.62
+0.69
+1.98%
After Hours: 35.62 0 0.00% 16:04 07/14 EDT
OPEN
35.33
PREV CLOSE
34.93
HIGH
37.27
LOW
35.14
VOLUME
694.09K
TURNOVER
--
52 WEEK HIGH
59.23
52 WEEK LOW
20.85
MARKET CAP
1.31B
P/E (TTM)
-58.6820
1D
5D
1M
3M
1Y
5Y
1D
Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar?
NASDAQ · 10h ago
Weekly Report: what happened at HROW last week (0707-0711)?
Weekly Report · 12h ago
Harrow's Internal $100 Price Target Is Ambitious, But New Bloomberg Data Backs It Up
Seeking Alpha · 3d ago
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Benzinga · 3d ago
Harrow jumps as Cantor initiates with Bullish view on conservative outlook
Seeking Alpha · 3d ago
CoreWeave initiated, Texas Instruments upgraded: Wall Street’s top analyst calls
TipRanks · 3d ago
Video: Capricor plunges after CRL, Performance Foods up after seeing interest
TipRanks · 3d ago
Harrow Price Target Announced at $76.00/Share by Cantor Fitzgerald
Dow Jones · 3d ago
More
About HROW
Harrow, Inc. is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the North American market. The Company offers a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. It owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. It owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE, BYQLOVI and others. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% is a low-viscosity gel indicated for ocular surface anesthesia.

Webull offers Harrow Inc stock information, including NASDAQ: HROW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HROW stock methods without spending real money on the virtual paper trading platform.